BOSTON (MA), June 5, 2018 – Pfizer Canada is proud to announce a $1,200,000 contribution to the NEOMED Institute. Pfizer Canada’s support will help NEOMED in its mission to accelerate the transformation of scientific discoveries from Quebec and Canadian universities into innovative therapeutic treatments.
Over the next three
GSK and NEOMED are calling on Quebec-based researchers to submit their innovative projects in early drug discovery for potential funding under the GSK and NEOMED $2 million Discovery Fund.Montreal, QC, Canada May 31st, 2018 – Today, GlaxoSmithKline Inc. (GSK) and the NEOMED Institute (NEOMED) are inviting
Montreal, Quebec, Canada May 3rd, 2018 – The NEOMED Institute announced today that it has entered into a development collaboration with McGill University. Dr. Kemal Payza, Senior Project Director at NEOMED Institute will collaborate with Dr. Alain Nepveu, Professor at the Goodman Cancer Research Centre and Departments